Subscription to news, schedules, federal budget and appropriations
ID: 75F40124R00186Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA OFFICE OF ACQ GRANT SVCSBeltsville, MD, 20705, USA

NAICS

Software Publishers (513210)

PSC

NEWSPAPERS AND PERIODICALS (7630)

Original Source

https://sam.gov/opp/3c012f77da184c5cabf51e8042d43c4d/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking to procure subscriptions to Budget Tracker for six individuals, aimed at enhancing legislative tracking and budget monitoring capabilities. The procurement includes a base year subscription with options for four additional years, providing essential documents related to appropriation bills, detailed bill status charts, and legislative analysis. These subscriptions are critical for the FDA's Office of Regulatory Affairs to maintain continuous access to vital financial and legislative information, particularly during periods of congressional delays in finalizing appropriations. Interested vendors should contact Valrica Manns at valrica.manns@fda.hhs.gov or call 301-837-7507 for further details, with the anticipated period of performance extending from August 2024 to August 2029.

    Point(s) of Contact
    Valrica Manns
    (301) 837-7507
    valrica.manns@fda.hhs.gov
    Files
    Title
    Posted
    ORA BNJ.pdf
    The document outlines a Brand Name Justification for the acquisition of Budget Trucker subscriptions by the U.S. Food and Drug Administration (FDA). It serves to justify an exception to fair opportunity under federal procurement regulations (FAR 16.505). The FDA's Office of Regulatory Affairs requires these subscriptions to maintain 24/7 access to legislative tracking tools vital for monitoring financial plans, budget estimates, congressional hearings, and appropriations. The incumbent contractor, CQ Roll Call Inc., has been providing these services, which are critical to the FDA’s mission of safeguarding public health. The projected acquisition includes subscriptions for six individuals, with specified funding for a base year and options for four additional years. Utilizing alternative services is deemed insufficient for meeting the FDA's objectives. The action is classified as a follow-on requirement and is expected to be offered as a firm-fixed-price contract, ensuring a fair cost to the government while allowing competition through SAM.gov. The document emphasizes the necessity of these subscriptions for effective regulatory management and outlines steps to enhance competition in future acquisitions.
    RFP No. 75F40124R00186 ORA Roll Call.pdf
    The document is a combined synopsis and solicitation for a CQ Roll Call subscription aimed at providing legislative and budgetary insights specifically for the FDA's Office of Regulatory Affairs. It requests quotes to acquire six subscriptions for a base year with four optional renewal years, classified under NAICS code 513210 for Software Publishers. The key objectives include real-time updates on budget and appropriations activities, which are essential for FDA management during a fiscal year that often begins without finalized appropriations due to Congressional delays. The description outlines the services included in the CQ subscription, such as daily news reports, legislative schedules, and specific budget tracking tools to aid in systematic monitoring of federal budget processes. The anticipated period of performance is from August 2024 to August 2029. The contracting officer has sole authority to modify agreements, while inspections and acceptance of services will occur at designated FDA facilities. Compliance with federal procurement regulations is necessary throughout the contracting process, along with adherence to billing and invoicing functionalities using the Department of Treasury's IPP system. Overall, this solicitation supports the FDA's operational continuity and response capabilities amidst the complexities of budget formulation and execution.
    Lifecycle
    Title
    Type
    Subscription to news, schedules, federal budget and appropriations
    Currently viewing
    Solicitation
    Similar Opportunities
    FDA Library Digital Subscription Services and Support
    Active
    Health And Human Services, Department Of
    The Food and Drug Administration (FDA) is seeking qualified vendors to provide digital subscription services and support for its library resources, aimed at enhancing access to credible scientific information for its staff. The procurement involves establishing a Blanket Purchase Agreement that consolidates subscription management, covering renewals and purchases of journals, databases, and training materials, while ensuring these resources are accessible through a secure online tracking system. This initiative is crucial for maintaining an extensive and well-managed library that supports the FDA's public health mission, ensuring reliable access to critical information for its employees. Interested vendors should submit their capabilities statements by September 23, 2024, to Vivianna Diaz at Vivianna.Diaz@fda.hhs.gov, with a total funding allowance of $450,000 for unforeseen subscription changes over the contract period from January 1, 2025, to January 31, 2030.
    Facility Management System (FMS) Administration and Data Management
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified vendors for the administration and data management of its Facility Management System (FMS), utilizing the ARCHIBUS software. The contractor will be responsible for providing ongoing FMS support, ensuring compliance with federal reporting requirements, maintaining data integrity, and offering user training and technical assistance. This initiative is crucial for managing the FDA's facilities efficiently in response to increasing service demands and regulatory requirements, with the contract anticipated to span from March 24, 2025, to March 23, 2030. Interested parties must submit their responses, including a Vendor Feedback Form, to Nicholas Bisher and Kimberly Pennix by September 23, 2024, at 2:00 PM EST, as this is a Sources Sought Notice and not a solicitation for proposals.
    Software Component Package Risk & Vulnerability Periodic Database
    Active
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is seeking to award a firm fixed price purchase order for a Software Component Package Risk and Vulnerability Periodic Database to Dark Sky Technology, Inc. This procurement aims to enhance the cybersecurity of medical devices by acquiring a subscription service that reports known software vulnerabilities, which is critical for the FDA's Center for Devices and Radiological Health (CDRH) to effectively assess and mitigate risks associated with medical device software. The initiative is part of the FDA's response to the Food and Drug Omnibus Reform Act of 2022, emphasizing the importance of safeguarding public health in an evolving technological landscape. Interested parties can contact Brian Wodzisz at Brian.Wodzisz@fda.hhs.gov for further information, with the contract performance period extending up to five years.
    DM: Prediction Model Software
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking advanced prediction model software to enhance product quality and efficiency within its Division of Product Quality and Research (DPQR). The software must be capable of mining large and complex datasets to identify critical quality parameters and optimize product performance at a molecular level, particularly in a high-performance computing (HPC) environment. This procurement is vital for addressing product quality issues in pharmaceutical manufacturing and ensuring compliance with FDA standards. Interested vendors should contact Allison Meads at allison.meads@fda.hhs.gov or Steven Gagnon at steven.gagnon@fda.hhs.gov for further details, as the contract will follow a firm fixed price model with specific deliverables and a performance period extending until installation and warranty completion.
    PRIMO Software Licensing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide PRIMO Software Licensing and Maintenance Support Services. The procurement involves supplying 21 PRIMO software licenses for a base year, with two additional option years, to ensure the continuous operation of the FDA's CFSAN CAEMS system. This software is crucial for pharmacovigilance and regulatory compliance, enhancing the FDA's capabilities in monitoring food safety. Interested parties must submit their quotes by August 26, 2024, and are encouraged to contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov for further details. The contract will be awarded as a firm-fixed-price purchase order, emphasizing compliance with federal acquisition regulations and accessibility standards.
    Engineering and Application Support Services
    Active
    Health And Human Services, Department Of
    The Food and Drug Administration (FDA) is seeking qualified small businesses to provide Engineering and Application Support Services aimed at modernizing its IT infrastructure and application environments. The procurement focuses on DevSecCXOps, Innovation, Modernization, and Engineering Services, with an emphasis on IT project management, infrastructure modernization, and operational support. This initiative is critical for enhancing the FDA's technological capabilities to ensure public health safety and streamline service delivery. Interested contractors must submit their responses by September 30, 2024, detailing their corporate profiles and relevant experience, with a projected contract value of up to $80 million. For further inquiries, potential bidders can contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov.
    Software Bill of Materials (SBOM) Validation Comparison Set
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration's Center for Devices and Radiological Health (CDRH), is seeking to award a firm fixed price purchase order to MedCrypt, Inc. for the development of a Software Bill of Materials (SBOM) Validation Comparison Dataset. The primary objective of this procurement is to enhance cybersecurity for medical devices by providing a continuously updated dataset of known vulnerabilities, which will aid in the analysis of risks and potential exploits associated with software components used in these devices. This initiative is crucial for ensuring the safety and efficacy of healthcare technologies, particularly in light of recent legislative mandates under the Food and Drug Omnibus Reform Act of 2022. Interested parties can contact Brian Wodzisz at Brian.Wodzisz@fda.hhs.gov for further information regarding this opportunity.
    Contractor Laboratory Support Services and Disposal of Packaging Materials
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is soliciting contractor support for laboratory support services and the disposal of packaging materials under RFQ 75F40124Q00549. The contractor will be responsible for tasks including the disposal of refrigerated sample boxes, handling dry ice, and maintaining a clean laboratory environment, while ensuring compliance with OSHA regulations and supporting laboratory safety checks. This contract is crucial for maintaining operational efficiency and safety within the FDA's Office of Compliance and Biologics Quality (OCBQ) and is expected to span a three-year period from September 30, 2024, to September 29, 2027, with a firm-fixed price structure. Interested contractors should submit their quotes electronically, adhering to specified guidelines, and can contact Matthew Tran at matthew.tran@fda.hhs.gov for further information.
    Software License and Device Warranty for Two Nanopore GridION Instruments
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking to procure a Software License and Device Warranty for two Nanopore GridION instruments, which are critical for the FDA's Next Generation Sequencing (NGS) initiatives focused on genomic data collection and analysis. The procurement aims to ensure optimal performance of these instruments through software and hardware updates, remote troubleshooting, and a return and replace policy for faulty devices, with a total cost of $25,000 for a one-year warranty and license renewal. This acquisition underscores the FDA's commitment to enhancing pathogen identification capabilities through advanced genomic technology, with the performance period set from September 28, 2024, to September 27, 2025, and the possibility of extending for three additional years, subject to funding. Interested vendors should submit their quotes electronically to Raphael Hall at raphael.hall@fda.hhs.gov by September 19, 2024, at 11:59 PM Eastern Standard Time.
    CFSAN Security Radio Upgrade & Security Communications Support Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is seeking proposals for the CFSAN Security Radio Upgrade & Security Communications Support Services contract. The primary objective is to enhance communication and emergency response capabilities at the College Park, Maryland campus by providing telecommunication devices, including 30 handheld radios with advanced features, and associated support services. This initiative is crucial for ensuring effective coordination, safety, and security during emergencies, while adhering to federal security requirements. Proposals are due by September 23, 2024, and interested parties can contact Matthew Tran at matthew.tran@fda.hhs.gov for further information.